Tech Company Financing Transactions
SurgRx Funding Round
SurgRx closed a $21 million Series E funding round on 7/25/2005. Investors included New Enterprise Associates.
Transaction Overview
Company Name
Announced On
7/25/2005
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series E
Investors
New Enterprise Associates (Lead Investor) (Sigrid VanBladel)
Proceeds Purpose
Funds will be used to aid the company in marketing EnSeal products internationally
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
101 Saginaw Drive
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
SurgRx, a medical device manufacturer based in Palo Alto, California. SurgRx is the developer of the EnSeal System, a proprietary, FDA-approved technology that empowers surgeons to cut and seal blood vessels and tissue quickly, efficiently, and with virtually no unwanted effects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Csaba Truckai
Browse more venture capital transactions:
Prev: 7/25/2005: Primarion venture capital transaction
Next: 7/25/2005: TherOx venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs